SCHEMBL2844063

SCHEMBL2844063

CC(=O)Nc1ccc(Oc2ccc(O)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.77
MEN1 O00255 4/20 0.77
MAPT P10636 2/20 0.77
ALDH1A1 P00352 2/20 0.77
CA1 P00915 2/20 0.77
CA2 P00918 2/20 0.77
CA9 Q16790 2/20 0.77
CA12 O43570 1/20 0.77
BRD4 O60885 1/20 0.77
NR1I2 O75469 1/20 0.77
MB P02144 1/20 0.77
CYP1A1 P04798 1/20 0.77
CA3 P07451 1/20 0.77
CYP3A4 P08684 1/20 0.77
RARG P13631 1/20 0.77
TSHR P16473 1/20 0.77
ALOX5AP P20292 1/20 0.77
CA4 P22748 1/20 0.77
CA7 P43166 1/20 0.77
NR1I3 Q14994 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6516221 0.92 KMT2A (0.73) KMT2AMEN1MAPTALDH1A1CA1
Acetaminophen SCHEMBL8937727 0.88 KMT2A (1.00) KMT2AMEN1MAPTALDH1A1CA1
Acetaminophen SCHEMBL252939 0.88 KMT2A (1.00) KMT2AMEN1MAPTALDH1A1CA1
Acetaminophen SCHEMBL3480 0.88 KMT2A (1.00) KMT2AMEN1MAPTALDH1A1CA1
SCHEMBL18826484 0.86 KMT2A (0.66) KMT2AMEN1MAPTALDH1A1CA1
Acetaminophen SCHEMBL29086803 0.86 KMT2A (0.87) KMT2AMEN1MAPTALDH1A1CA1
Acetaminophen SCHEMBL5081499 0.86 KMT2A (0.95) KMT2AMEN1MAPTALDH1A1CA1
Acetaminophen SCHEMBL8959271 0.86 KMT2A (0.95) KMT2AMEN1MAPTALDH1A1CA1
Acetaminophen SCHEMBL20541508 0.86 ALDH1A1 (0.95) KMT2AMEN1MAPTALDH1A1CA1
Acetaminophen SCHEMBL10325382 0.86 KMT2A (0.95) KMT2AMEN1MAPTALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 KMT2A 1371/4885MEN1 3895/4885MAPT 2608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.